BRIGHTSPRING HEALTH SERVICES, INC. Financials BrightSpring Health Services, Inc.
Equities
BTSG
US10950A1060
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.25 USD | -1.75% |
|
-0.62% | -.--% |
| 22/05 | BrightSpring Health Services Completes Three Acquisitions | MT |
| 20/05 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 1,927 | - | - |
| Enterprise Value (EV) 1 | 4,312 | 4,129 | 3,898 |
| P/E ratio | 16.2 x | 10.9 x | 9.03 x |
| Yield | - | - | - |
| Capitalization / Revenue | 0.18 x | 0.17 x | 0.15 x |
| EV / Revenue | 0.41 x | 0.36 x | 0.31 x |
| EV / EBITDA | 7.64 x | 6.71 x | 5.83 x |
| EV / FCF | 21.8 x | 17.7 x | - |
| FCF Yield | 4.59% | 5.66% | - |
| Price to Book | 1.24 x | 1.1 x | 0.96 x |
| Nbr of stocks (in thousands) | 1,71,320 | - | - |
| Reference price 2 | 11.25 | 11.25 | 11.25 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 8,826 | 10,607 | 11,422 | 12,472 |
| EBITDA 1 | - | 537.8 | 564.6 | 615.7 | 668.6 |
| EBIT 1 | - | 335.5 | 355.5 | 377 | 426.1 |
| Operating Margin | - | 3.8% | 3.35% | 3.3% | 3.42% |
| Earnings before Tax (EBT) 1 | - | -177.4 | 71.73 | 210.3 | 265.8 |
| Net income 1 | -53.91 | -154.6 | 118.2 | 205.4 | 283.7 |
| Net margin | - | -1.75% | 1.11% | 1.8% | 2.27% |
| EPS 2 | -7.180 | -1.310 | 0.6929 | 1.034 | 1.246 |
| Free Cash Flow 1 | - | 137.3 | 197.9 | 233.6 | - |
| FCF margin | - | 1.56% | 1.87% | 2.05% | - |
| FCF Conversion (EBITDA) | - | 25.52% | 35.05% | 37.95% | - |
| FCF Conversion (Net income) | - | - | 167.4% | 113.75% | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 28/08/23 | 29/02/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,375 | 2,577 | 2,619 | 2,656 | 2,754 | 2,784 | 2,834 |
| EBITDA 1 | 142.6 | 130.5 | 140.6 | 141.1 | 151.8 | 143 | 157.2 |
| EBIT 1 | 91.59 | 81.58 | 84.77 | 88.49 | 95.75 | 87.72 | 89.57 |
| Operating Margin | 3.86% | 3.17% | 3.24% | 3.33% | 3.48% | 3.15% | 3.16% |
| Earnings before Tax (EBT) | -14.79 | - | - | - | - | - | - |
| Net income 1 | -6.537 | -45.75 | 41.05 | 40.92 | 49.07 | 51.68 | 68.27 |
| Net margin | -0.28% | -1.78% | 1.57% | 1.54% | 1.78% | 1.86% | 2.41% |
| EPS 2 | -0.0600 | -0.2600 | 0.2132 | 0.2256 | 0.2662 | 0.2636 | 0.3282 |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 29/02/24 | 02/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 3,385 | 2,385 | 2,201 | 1,971 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 6.294 x | 4.223 x | 3.575 x | 2.948 x |
| Free Cash Flow 1 | - | 137 | 198 | 234 | - |
| ROE (net income / shareholders' equity) | - | 1.77% | 9.72% | 9.01% | 9.71% |
| ROA (Net income/ Total Assets) | - | 0.22% | 5.72% | 6.4% | 6.57% |
| Assets 1 | - | -71,609 | 2,065 | 3,211 | 4,318 |
| Book Value Per Share 2 | - | 4.960 | 9.090 | 10.20 | 11.70 |
| Cash Flow per Share 2 | - | 1.790 | 0.4000 | 1.740 | 2.210 |
| Capex 1 | - | 73.5 | 78 | 91.8 | 94.5 |
| Capex / Sales | - | 0.83% | 0.74% | 0.8% | 0.76% |
| Announcement Date | 28/08/23 | 29/02/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
11.25
USD
Average target price
16.05
USD
Spread / Average Target
+42.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 192.74Cr | |
| -4.11% | 297.85Cr | |
| +23.65% | 185.64Cr | |
| -11.21% | 46Cr | |
| -47.58% | 30Cr | |
| -19.40% | 17Cr | |
| -16.45% | 13Cr | |
| +1.92% | 6.78Cr |
- Stock Market
- Equities
- BTSG Stock
- Financials BrightSpring Health Services, Inc.
